DEVELOPMENT OF ANALYTICAL METHOD FOR IMATINIB MESYLATE BY ULTRAVIOLET SPECTROSCOPY

AJITHKUMAR P; ANTON SMITH A

doi:10.22159/ajpcr.2020.v13i1.36098

Authors

AJITHKUMAR P Department of Pharmacy, Faculty of Engineering and Technology, Annamalai University, Chidambaram, Tamil Nadu, India.
ANTON SMITH A Department of Pharmacy, Faculty of Engineering and Technology, Annamalai University, Chidambaram, Tamil Nadu, India.

DOI:

https://doi.org/10.22159/ajpcr.2020.v13i1.36098

Keywords:

Spectrophotometer, Imatinib mesylate, Determination

Abstract

Objective: A simple, selective, sensitive, specific, and spectrophotometric method has been developed for the detection of imatinib mesylate in pure form and formulations.

Methods: The analytical condition was optimized for the drug, carried out as per the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use guidelines.

Results: The drug shows absorption at 232.0 nm and obeyed beers law in the wide concentration range from 0.5 to 4.0 μg/ml. The lower limit of detection was found to be 0.331 μg/ml and the limit of quantification to be 1.004 μg/ml. The regression equation was found to be y = 0.08x. The precision of the method was found to be 99.04%±0.527% and the percentage of drug recovered by this method is 100.13%±1.375%.

Conclusion: The method is simple and suitable for determination for imatinib mesylate in pure and pharmaceutical preparation.

Downloads

Download data is not yet available.

References

Sweetman SC. Martindale: The Complete Drug Reference. 36th ed. London: Pharmaceutical Press; 2009. p. 773-4.

Bende G, Kollipara S, Sekar V, Saha R. UV-spectrophotometric determination of imatinib mesylate and its application in solubility studies. Pharmazie 2008;63:641-5.

Camila T, Pedro LG, Fabio PG, Erika RM, Inês RM. Quantitative determination of nadolol in tablets by high-performance liquid chromatography and UV-derivative spectrophotometry. Anal Lett 2008;41:424-36.

Olajire A, Olakunle SI, Olaniyi AA. A new spectrophotometric method for the determination of nadolol. J Iran Chem Soc 2006;3:277-84.

Velpandian T, Mathur R, Agarwal NK, Arora B, Kumar L, Gupta SK. Development and validation of a simple liquid chromatographic method with ultraviolet detection for the determination of imatinib in biological samples. J Chromatogr B Analyt Technol Biomed Life Sci 2004;804:431-4.

Vijayalakshmi R, Sri RN, Dhanaraju M. Method development for quantification of oxidation complexes of nadolol and resveratrol by visible spectrophotometry. Int J Pharm Pharm Sci 2014;7:304-7.

Kuna AK, Kumar KJ. RP-HPLC method development and validation of imatinib mesylate in tablet dosage form. Int J Pharm Pharm Sci 2011;3:39-44.

Amin AS, Ragab GH, Saleh H. Colorimetric determination of beta-blockers in pharmaceutical formulations. J Pharm Biomed Anal 2002;30:1347-53.

Eugene I. Colorimetric determination of nadolol in Tablets. J Pharm Sci 1978;67:1024-5.

Oostendorp RL, Beijnen JH, Schellens JH, Tellingen Ov. Determination of imatinib mesylate and its main metabolite (CGP74588) in human plasma and murine specimens by ion-pairing reversed-phase high-performance liquid chromatography. Biomed Chromatogr 2007;21:747-54.

Patel BR, Kirschbaum JJ, Poet RB. High-pressure liquid chromatography of nadolol and other beta-adrenergic blocking drugs. J Pharm Sci 1981;70:336-8.

Chandana M. Method Development and validation for simultaneous estimation of nadolol and bendroflumethiazide in pharmaceutical dosage form by using RP-HPLC method. J Pharm Sci 2012;4:216-27.

Perlman S, Szyper M, Kirschbaum JJ. High-performance liquid chromatographic analysis of nadolol and bendroflumethiazide combination tablet formulations. J Pharm Sci 1984;73:259-61.

Ivanovic D, Medenica M, Jancic B, Malenovic A. Reversed-phase liquid chromatography analysis of imatinib mesylate and impurity product in glivec capsules. J Chromatogr B Analyt Technol Biomed Life Sci 2004;800:253-8.

Solassol F, Bressolle L, Philibert V, Charasson C, Astre, F. Liquid chromatography-electrospray mass spectrometry determination of imatinib and it’s main metabolite, N-desmethyl- imatinib in human plasma. J Liq Chromatogr Relat Technol 2006;29:2957-74.

Vivekanand VV, Rao DS, Vaidyanathan G, Sekhar NM, Kelkar SA, Puranik PR. A validated LC method for imatinib mesylate. J Pharm Biomed Anal 2003;33:879-89.

Wahajuddin LN, Singh SP, Jain GK. Determination of lumefantrine in rat plasma by liquid-liquid extraction using LC-MS/MS with electrospray ionization: Assay development, validation and application to a pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:1133-9.

Vivek R, Jose S. Development, evaluation and targeting of imatinib mesylate loaded solid lipid nanoparticles to the lymphatic system. Int J Pharm Sci Res 2018;9:2359-68.

European Medicines Agency. ICH Harmonized-Tripartite Guidelines, Validation of Analytical Procedure: Text and Methodology Q2 (R1); 2005.